Mesa Laboratories vs Schrodinger
Mesa Laboratories and Schrodinger are similar in size: $249m and $256m of revenue in their latest fiscal years. Schrodinger grew faster (23.3% against 3.4%). Mesa Laboratories kept more of each dollar of sales as profit: a net margin of 2.7% against -40.4%. Schrodinger carries less debt relative to equity (0.0% against 36.2%).
| Latest fiscal year | Mesa LaboratoriesMLAB, 2026 | SchrodingerSDGR, 2025 |
|---|---|---|
| Revenue | $249m | $256m |
| Revenue growth | 3.4% | 23.3% |
| Net income | $6.7m | −$103m |
| Operating margin | 7.4% | -65.2% |
| Net margin | 2.7% | -40.4% |
| Return on equity | 3.9% | -26.3% |
| Free cash flow | $39.6m | $12.5m |
| Cash | $26.9m | $231m |
| Total debt | $67.5m | $0 |
| Debt to equity | 36.2% | 0.0% |
| Dividend per share | $0.64 | — |
| Dividend yield | 0.5% | — |
| Share buybacks | — | — |
| Employees | 717 | 850 |
| Market value | $683m | $1.98bn |
| Price vs our value range | Within our value range | — |
| Moat score | 44 (Weak) | 28 (Weak) |
| Insider trades, 12 months | 5 buys, 7 sales | 0 buys, 20 sales |